Searched for
SOUTH AFRICA DRUGMAKER
Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...- Indian cancer patients battle shortage of key drugs as platinum costs surgeCancer patients in India are struggling to find essential platinum-based drugs. A surge in global platinum prices and supply chain issues a...
- Experts say a twice-yearly injection that offers 100% protection against HIV is 'stunning'The shots made by U.S. drugmaker Gilead and sold as Sunlenca are approved in the U.S., Canada, Europe and elsewhere, but only as a treatmen...
- European Commission authorises GSK's HIV prevention drugCabotegravir is recommended in combination with safer sex practices for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually-acqu...
- Africa needs to make own vaccines but hurdles are high, experts sayMartin Friede, coordinator of the World Health Organisation Initiative for Vaccine Research, said Africa had produced many scientific resea...
- South Africa suspends 2 million Johnson & Johnson dosesFollowing a review of the FDA decision, the South African Health Products Regulatory Authority (SAHPRA) said in a statement that it had dec...
- Pfizer COVID-19 shot 91% effective in updated data, protective against South African variantThe shot was also 100% effective in preventing illness among trial participants in South Africa, where a new variant called B1351 is domina...
- Saudi Arabia to get three million AstraZeneca shots in a week from India's Serum InstituteSII, the world's biggest vaccine manufacturer, has partnered with AstraZeneca, the Gates Foundation and the Gavi vaccine alliance to make u...
- India to begin commercial vaccine exports with shipments to Brazil, MoroccoThe shots developed by UK-based drugmaker AstraZeneca and Oxford University are being manufactured at the Serum Institute of India, the wor...
- Pfizer vaccine appears effective against mutation in new coronavirus variants: StudyThe not-yet peer reviewed study by Pfizer and scientists from the University of Texas Medical Branch indicated the vaccine was effective in...
- AstraZeneca resumes vaccine trial in Japan, in talks with U.S.Several global trials of the vaccine, AZD1222, were put on hold last month after an unexplained illness in a study participant. While most ...
- Cipla divests animal health business in South Africa, sub-Saharan AfricaThe deal comes with a potential revision linked to FY17 performance along with customary adjustment (within the price band of 250 mn Rand a...
- Cipla signs pact with Teva Pharmaceuticals for selling drugs in South AfricaThe collaboration will focus on oncology, central nervous system, women's health, cardiovascular, ophthalmology and other speciality produc...
- Roselabs talks with PEs, inks Brazilian dealZameer Agrawal, director, Roselabs Biosciences Ltd, said, "We have recently entered into a $20 million contract supply deal with a Brazilia...
- Cipla Medpro shareholder wants Cipla India to hike offer: ReportCipla Medpro is a South African affiliate of Cipla. The companies enjoy a long-standing business relationship spanning two decades.
- Cipla puts Medpro buyout on hold over valuation issuesCipla decides to put on hold its $220-million acquisition plan of the third-largest South African drugmaker Cipla Medpro due to valuation i...
- Cipla set to buy 51% of S Africa's Cipla Medpro for about $220 millionCipla said on Wednesday it will buy 51% of Cipla Medpro for about $220 million, valuing the beleaguered South African company at about $440...
- Cipla looking to expand contraceptive pills business; in talks with International Planned ParenthoodThe country's second-largest pharmaceuticals company, Cipla, is in talks with an international health group to expand its contraceptive pil...
- Ranbaxy launches cholesterol drug in SAfricaRanbaxy Laboratories, India's largest drugmaker by sales, said on Tuesday its unit had launched atorvastatin, generic form of Pfizer Inc's ...
- Indian firms get lion's share in US anti-AIDS fundingAurobindo Pharma, Cipla and Ranbaxy, have received a lion's share of over 85 per cent in the US government's latest fiscal funding for AIDS...
Load More
